Summit Therapeutics Announces U.S. FDA Acceptance of Biologics License Application (BLA) Seeking Approval for Ivonescimab in Combination with Chemothe…

Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today announced that the U.S. Food & Drug ...
pharmaphorum

FDA starts review of Summit's VEGFxPD-1 bispecific

Summit Therapeutics has moved ahead in the race to bring a therapy targeting both VEGF and PD- (L)1 to market, after the FDA started a review of its ivonescimab drug for lung cancer.
Seeking Alpha

Summit stock jumps as FDA grants fast track tag for lung cancer therapy

Summit Therapeutics (NASDAQ:SMMT) shares rose as much as 25% in premarket trading on Friday after the company secured FDA’s Fast Track designation for the proposed use of its cancer drug, ivonescimab, ...
Psychology Today

Summit Therapy, PLLC

I treat motivated individuals who struggle with suicidal ideation, self harm, anxiety, and depression. Clients can expect a comprehensive program addressing multiple life domains, in depth CBT, trauma ...
Summit County

Letter to the editor: Therapy dogs are a great support for the community

In the wee hours of Sept. 5, 2024, Summit and Delta counties lost a valued member of our communities. Our 5-year-old Australian Shepherd, Jigs, passed away at his home from a rare form of intestinal ...
AOL

Summit Therapeutics' Lung Cancer Therapy Ivonescimab Shows Improved Progression-Free Survival Versus Merck's Multi-Billion Keytruda In China Study

On Friday, Summit Therapeutics Inc (NASDAQ:SMMT) shares are trading lower after the company’s stock closed 272.1% higher at $10.92 on Thursday. HARMONi-2 evaluated monotherapy ivonescimab against ...
ARLnow.com

Reduce negativity and generate hope with family therapy at Summit Counseling

Arguments to get off electronics, isolating and not engaging with the rest of the family, and emotional outbursts directed at parents are probably a sign your child is struggling and the family system ...